CTA demonstrated hepatic artery aneurysm; gastroscopy showed chronic superficial gastritis. Total protein 53.8g/L; protein 33.6g/L; alanine transaminase 8U/L; 9.73 mmol/L urea creatinine uric acid; 178 umol/L; 446 umol/L; cystatin C 1.9 mg/L sodium chloride; 148 mmol/L; 113.2 mmol/L; osmotic pressure of 300 2.5 mmol/L; After admission in patients with melena 1 time, syncope, give blood, hemostatic measures. In stable condition

after the turn of Hunan Province, the Second Affiliated Hospital of Xiangya vascular interventional treatment, telephone follow-up has no black stool. Conclusion: The Dabrafenib final diagnosis: gastrointestinal hemorrhage, hepatic artery aneurysm rupture and bleeding. Key Word(s): 1. Hepatic; 2. artery aneurysm; 3. bleeding; 4. abdominal

pain; Presenting Author: XINGSHUN QI Additional Authors: GUOHONG HAN Corresponding Author: XINGSHUN QI Affiliations: Xijing Hospital of Digestive selleck Diseases Objective: Background & Aims: The obstructive location and risk factors of Budd-Chiari syndrome (BCS) are substantially different between Western countries and China. In West, transjugular intrahepatic portosytemic shunt (TIPS) is widely applied for the treatment of BCS. However, the outcome of Chinese BCS patients treated with TIPS is extremely limited. Whether or not Western experiences could extrapolate to Chinese patients remains unclear. Methods: Methods: All consecutive BCS patients treated with TIPS between December 2004 and June 2012 MCE公司 were included. TIPS procedure-related complications, post-TIPS hepatic encephalopathy, shunt dysfunction, and death were reported. Predictors of hepatic encephalopathy, shunt dysfunction, and overall survival were also determined. Results: Results: Of 51 patients included, 39 underwent percutaneous recanalization 1024 days (0-4574) before TIPS; 42 had diffuse HV obstruction; and 22 and 13 presented with variceal bleeding and large ascites, respectively. Procedure-related intraperitoneal bleeding was reversible in 3 patients. The

cumulative 1-year rate of being free of post-TIPS hepatic encephalopathy and shunt dysfunction was 78.38% and 61.69%, respectively. Pre-TIPS hepatic encephalopathy and covered stents could predict the development of post-TIPS hepatic encephalopathy. Inferior vena cava thrombosis could predict the development of shunt dysfunction. The cumulative 1-, 2-, and 3-year survival rates were 83.82%, 81.20%, and 76.93%, respectively. BCS-TIPS score, but not Child-Pugh, MELD, Clichy, or Rotterdam score, could predict the survival. Univariate analysis also showed that age, total bilirubin, and inferior vena cava thrombosis were significantly associated with overall survival. Conclusion: Conclusions: TIPS can achieve an excellent survival in Chinese BCS patients. BCS-TIPS score could effectively predict these patients’ survival. Key Word(s): 1. Budd Chiari syndrome; 2.